Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Alise S. Reicin M.D., Ph.D. | President, CEO, Secretary & Director | 819.4k | -- | 1961 |
| Dr. Marcella K. Ruddy M.D., M.S. | Chief Medical Officer | 620.98k | -- | 1963 |
| Mr. Daniel Lochner M.B.A. | Chief Financial Officer | -- | -- | 1982 |
| Dr. Peter McNamara Ph.D. | Chief Scientific Officer | -- | -- | 1971 |
| Mr. Barry Rubenstein M.S. | Senior Vice President of People & Culture | -- | -- | -- |
| Mr. Anthony Muslin M.D. | Chief Development Officer | -- | -- | -- |
| Dr. Marc Schwabish Ph.D. | Chief Business Officer | -- | -- | 1981 |
| John Diener | Senior Vice President of Antibody Engineering & Protein Sciences | -- | -- | -- |
Tectonic Therapeutic, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 44
Description
Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts.
Corporate Governance
Upcoming Events
March 12, 2025 at 8:00 PM UTC - March 17, 2025 at 8:00 PM UTC
Tectonic Therapeutic, Inc. Earnings Date
Recent Events
July 26, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission